Capital Wealth
FRI CLOSE · OCT 2   S&P 500 7,722.72 ▲0.73%  ·  DJIA 51,176.96 ▲0.49%  ·  NASDAQ 27,190.86 ▲1.19%  ·  10-YR 5.28%  ·  2-YR 4.82%  ·  WTI $91.11 ▼1.9%  ·  GOLD $4,133.70 ▼0.9%  ·  VIX 15.31 ▼6.6%
Off Duty · Adventure & Travel · Health Costs · M5

Club Menopause Has a Spa Wing: $3,700 in the Dolomites, $2,880 Near Cancún — and Peptides the FDA Hasn’t Approved

Hormones ended the hot flashes; a Dolomites detox and a Cancún reset helped with some of the rest. Midlife health care is a real line in the retirement budget — and a spa doctor’s unapproved peptides are a cost of a different kind.

By Sean Anees Saifi · Capital Wealth · Published Sunday, October 4, 2026 · Source: The Wall Street Journal, October 3–4, 2026 weekend edition, whose market figures are the Friday, October 2 close (Off Duty)
Key Points
$3,700
Palace Merano’s four-day program, plus ~$500 a night
$2,880
Sha Mexico’s four-day reset, atop a $1,800 health pack
$4,442
Mayrlife’s seven-day Meno Classic, plus ~$545 a night
$28.8 billion
menopause market projected for 2033, from $18.7B now
A steaming indoor pool with a wooden lounger, folded white towels and a cup of herbal tea, snow-capped mountains through the floor-to-ceiling windows.
Palace Merano, a 120-year-old hotel turned medical spa below the Dolomites, sits a 2.5-hour drive from Milan — after the 9-hour flight.
In one line: Menopause is now an $18.7 billion market with a luxury-spa wing, and the sensible way to shop it is as a health cost: priced in full, checked for eligibility, and skeptical of anything without trials behind it.

Amy Tara Koch turned 55 and, by her account, her tidy life came apart at the seams: no sleep, night sweats, anxiety up, libido gone, and a waistline that staged a sit-in against her favorite jeans. She’d been drafted, she writes, into “Club Menopause, a membership about as unsexy as AARP.” Her first-person piece in this weekend’s Journal Off Duty is a dispatch from the clubhouse — which turns out to be a circuit of medical spas that bill in the thousands.

Medicine came first. Bijuva, the bioidentical hormone her gynecologist prescribed, barely moved the needle; a year on, a menopause specialist’s patch, cream and pills ended the hot flashes and the sleepless nights without making her feel like herself. So she followed a friend’s tip to Palace Merano, below Italy’s Dolomites — a 9-hour flight, then a 2.5-hour drive up from Milan, rewarded with fennel tea where a Negroni should’ve been. The four-day Detox & Longevity program runs around $3,700, plus roughly $500 a night, and pairs Traditional Chinese Medicine with Western science: a diagnostic panel, vitamin B and glutathione drips, acupuncture, cupping, mud, and a menu without cheese, red meat, white bread or pasta. She left sharper, steadier under stress and 5 pounds lighter, while conceding that four days can’t rewrite hormonal biology.

The Cancún wing, with fine print

Sha Mexico, in Costa Mujeres just north of Cancún, sold her two line items: a Women’s Health Pack ($1,800) with hormone testing and gynecologic consults, and the four-day Rebalance & Energize program ($2,880). The room was another $755 a night. It felt more like a vacation — paddleboards, movie nights, fresh fish — until a doctor, hearing she couldn’t focus, floated two things the FDA hasn’t approved — the peptide Semax and oral oxytocin — plus exosome treatments. She did try the exosomes, two inhaled doses, and felt calmer for a while; within a week of getting home, her thoughts were racing again. Northwestern’s Dr. Lauren Streicher says there aren’t enough clinical trials to know what peptides and exosomes do over the long run. “The wellness landscape is filled with unproven remedies,” she told the Journal.

The business isn’t slowing down. Grand View Research puts menopause — skin care, cooling products, supplements — at $18.7 billion, headed for $28.8 billion by 2033, and the Global Wellness Summit called women’s longevity programs a top trend for 2026. Koch’s next booking is Mayrlife in the Austrian Alps: seven days of Meno Classic for around $4,442, plus about $545 a night. Colon irrigation and hypoxia training are on the card; she suspects the lake swims will do more.

Our read

This is a Health Costs and Cash Flow (M5) story in a bathrobe. Midlife care — specialist visits, hormone prescriptions, testing — is a real, recurring line in a retirement budget, and it often lands in the decade of the biggest savings decisions. Give it its own line instead of raiding the travel fund or the emergency cash. Some of a trip like Koch’s may be medical and some plainly isn’t; whether any of it can be paid from an HSA or FSA turns on IRS rules and documentation, not the spa’s brochure, so check with your plan administrator or a tax pro before you book, not after. And price the whole trip: the program fee is only the headline, and at $500 to $755 a night the room alone can add thousands.

Then bring the skepticism you’d bring to a hot stock tip. A treatment without FDA approval or solid trial data behind it isn’t a bargain at any price; it’s an unpriced risk, and that’s a cost too. Pay for what’s proven, enjoy the pool as the vacation it is, and keep the two ledgers honest. A fast-growing market means more people selling answers — it doesn’t mean more answers. Sketch the midlife-care line on a dry afternoon; it’s a lot harder to find the umbrella at 3 a.m. in a night sweat.

What It Means For Your Portfolio

Watch — price midlife care in full, and ask for evidence

No portfolio action — give midlife health care its own budget line, price any wellness trip in full, check HSA/FSA eligibility before you book, and treat unapproved treatments as a risk, not a perk.

General planning principles, not advice for anyone in particular. Menopause care — specialist visits, prescriptions, testing — is a recurring health cost for many households in the decade before retirement, and it belongs in the spending plan on its own line rather than as a raid on the travel or emergency fund.

Before a wellness trip, split the invoice in two: what’s medical care and what’s a vacation. Ask your plan administrator or a tax professional what, if anything, qualifies under IRS rules — don’t assume. And when a clinician suggests something that isn’t FDA-approved, the missing trials are the first cost to weigh.

Book a 15-Minute Review → Back to Edition No. 179 →